Articles Tagged With:
-
Addition of Alendronate to Ongoing HRT in the Treatment of Osteoporosis: A Randomized, Controlled Trial
-
Mode of Delivery and Neonatal Injury
-
P, 95CI, and Power
-
View the February 1998 issue of CenterWatch
Industry Reports
· Sponsors Send Mixed Message to CROs
· Bristol-Myers Squibb: A Reform Model for Partnering with CROs
· Month in ReviewReader's Corner
· Letter to the Editor
· CenterStageGrant Opportunities
· Eye on Melanoma
· Trial WatchPublisher's Letter
-
FDA adds to momentum to limit use of powdered latex gloves in hospitals
-
Latex allergy cases are costly to workers’ comp
-
National survey sparks dispute about latex risk
-
Going latex-free: Hospital takes it step by step
-
Wellness program pays for itself with lower claims
-
Wellness Challenge: Could you meet these criteria